FIELD: pharmaceuticals.
SUBSTANCE: invention relates to chemical-pharmaceutical industry, medicine, pharmacology and represents a solid dosage form presented in the form of tablets, antithrombotic action, characterized by that the active ingredient contains 9-(3,4-dihydroxy)phenacyl-2,3-dihydroimidazo[1,2-a]benzimidazole hydrobromide substance in following ratio of components, wt. %: 9-(3,4-dihydroxy)phenacyl-2,3-dihydroimidazo[1,2-a]benzimidazole hydrobromide – 72.17; lactose monohydrate – 8.02; calcium phosphate disubstituted – 13.37; corn starch – 4.54; plasdone K 29/32 with 10 % water – 1.50; calcium stearate – 0.40; and provides a combined mechanism of pharmacological action by blocking P2Y12 receptor and thromboxane synthesis inhibition.
EFFECT: invention provides extending the range of antithrombotics.
1 cl, 2 dwg, 7 tbl
Title | Year | Author | Number |
---|---|---|---|
AGENT SHOWING ANTIAGGREGANT AND ANTITHROMBOGENIC ACTIVITY | 2010 |
|
RU2453312C1 |
PHARMACEUTICAL COMPOSITION OF ANTIMIGRAINE ACTION IN SOLID DOSAGE FORM IN THE FORM OF TABLETS | 2019 |
|
RU2696866C1 |
1-(3-MORPHOLINOPROPYL)-2-PHENYLIMIDAZO[1,2-a]-BENZIMIDAZOLE DIHYDROCHLORIDE, HAVING PURINE P2Y-RECEPTOR ANTAGONIST PROPERTIES, ANTIAGGREGANT AND ANTITHROMBOTIC ACTIVITY | 2008 |
|
RU2391345C2 |
MEDICATION WHICH POSSESSES ANTITHROMBOGENIC ACTIVITY | 2010 |
|
RU2440814C1 |
COMBINATION POSSESSING ANTIAGGREGANT, LIPID-REGULATING AND GASTROPROTECTIVE ACTIVITIES, PHARMACEUTICAL COMPOSITION | 2010 |
|
RU2453314C1 |
PHARMACEUTICAL COMBINATION POSSESSING ANTIAGGREGANT AND LIPID-REGULATING ACTIVITIES, PHARMACEUTICAL COMPOSITION | 2010 |
|
RU2461379C2 |
ANTITHROMBOTIC AGENT AFFECTING REGULATION OF THROMBOCYTE CAPACITY | 2008 |
|
RU2377990C1 |
HAEMORHEOLOGIC AGENT CAPABLE OF REDUCING INSULING RESISTANCE AND RESTORING BODY TOLERANCE TO GLUCOSE AND PHARMACEUTICAL COMPOSITION BASED ON SAID AGENT | 2007 |
|
RU2386634C2 |
1-SUBSTITUTED-3-{[2-(3,5-DI-TRET-4-HYDROXYPHENYL)-2-OXOETHYL]}-2AMINOBENZIMIDAZOLIUM BROMIDES WITH ANTIPLATELET AND ANTIOXIDANT PROPERTIES | 2016 |
|
RU2623439C1 |
PHARMACEUTICAL COMPOSITION POSSESSING ANTIAGGREGANT ACTIVITY | 2019 |
|
RU2709017C1 |
Authors
Dates
2019-08-07—Published
2019-03-05—Filed